Kyoko Fujiwara

Years Active: 2017-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Eri Nagasaki-Maeoka, Kazuhiro Ikeda, Ken-Ichi Takayama, Takayuki Hirano, Yoshiaki Ishizuka, Tsugumichi Koshinaga, Naoya Tsukune, Tadateru Takayama, Satoshi Inouei, Kyoko Fujiwara
Polyethylene glycol derivative 9bw suppresses growth of neuroblastoma cells by inhibiting oxidative phosphorylation. Cancer science 111 (8) (2020)
Takayuki Hirano, Eri Nagasaki-Maeoka, Yoshiaki Ishizuka, Atsushi Takatori, Yosuke Watanabe, Reina Hoshi, Shinsuke Yoshizawa, Hiroyuki Kawashima, Shota Uekusa, Kiminobu Sugito, Shuichiro Uehara, Noboru Fukuda, Hiroki Nagase, Tadateru Takayama, Masayoshi Soma, Tsugumichi Koshinaga, Kyoko Fujiwara
Forced expression of NR4A3 induced the differentiation of human neuroblastoma-derived NB1 cells. Medical oncology (Northwood, London, England) 36 (8) (2019)
Yosuke Watanabe, Yoshiaki Ishizuka, Takayuki Hirano, Eri Nagasaki-Maeoka, Reina Hoshi, Shinsuke Yoshizawa, Shota Uekusa, Hiroyuki Kawashima, Kiminobu Sugito, Kenichi Shinohara, Noboru Fukuda, Hiroki Nagase, Masayoshi Soma, Tsugumichi Koshinaga, Kyoko Fujiwara
ZAR1 knockdown promotes the differentiation of human neuroblastoma cells by suppression of MYCN expression. Medical oncology (Northwood, London, England) 34 (9) (2017)

Kyoko Fujiwara.css-eqlu8i{font-size:small;padding-left:4px;}